| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Apr―17 |
Reevaluating thromboprophylaxis in COVID-19 outpatients: The case for a targeted, risk-based approach |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam |
| 2 |
[GO] |
2025―Apr―17 |
Reply: Reevaluating thromboprophylaxis in COVID-19 outpatients: The case for a targeted, risk-based approach |
Davide Di Vece, Jean M. Connors, Stefano Barco |
| 3 |
[GO] |
2025―Feb―27 |
Comparison of seven Artificial Intelligence models in Predicting Venous Thromboembolism in COVID-19 Patients |
Indika Rajakaruna, Mohammad Hossein Amirhosseini, Mike Makris, Mike Laffan, Yang Li, Deepa J. Arachchillage |
| 4 |
[GO] |
2025―Feb―09 |
Relevance of anti-PF4/H antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic |
Nicolas GENDRON, Dominique HELLEY, Johannes THALER, Dorothée FAILLE, Christine LE BELLER, Maxime GRUEST, Jérôme HADJADJ, Aurélien PHILIPPE, Faris ZECO, Marie COURBEBAISSE, Luc DARNIGE, Wafa AMARA, Leyla CALMETTE, Beatrice PARFAIT, Claire AUDITEAU, Richard CHOCRON, Lina KHIDER, Laetitia MAUGE, Olivier ESPITIA, Gérard FRIEDLANDER, Nadine AJZENBERG, David LEBEAUX, Benjamin PLANQUETTE, Olivier SANCHEZ, Jean-Luc DIEHL, Agnès LILLO-LE LOUET, Benjamin TERRIER, David M. SMADJA |
| 5 |
[GO] |
2024―Oct―30 |
Primary thromboprophylaxis in ambulatory symptomatic patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials |
Davide Di Vece, Marco Valgimigli, Elliot Barnathan, Jean M. Connors, Frank Cools, Ulrike Held, Ajay K. Kakkar, Gregory Piazza, David Spirk, Saverio Virdone, Nils Kucher, Stefano Barco |
| 6 |
[GO] |
2024―Sep―16 |
The impact of pulmonary embolism on health outcomes of COVID-19 at 3 months after hospitalization |
Chantal Visser, Julia C. Berentschot, Cindy M.M. de Jong, M. Louisa Antoni, L. Martine Bek, Rita J.G. van den Berg-Emons, Bram van den Borst, Hugo ten Cate, Arina J. ten Cate-Hoek, Dionne C.W. Braeken, J.J. Miranda Geelhoed, Majanka H. Heijenbrok-Kal, Sander M.J. van Kuijk, Lucia J.M. Kroft, Jenneke Leentjens, Anna H.E. Roukens, Suzanne C. Cannegieter, Frederikus A. Klok, Marieke J.H.A. Kruip, Merel E. Hellemons |
| 7 |
[GO] |
2024―Sep―10 |
Fibrinaloid microclots in Long COVID: assessing the actual evidence properly |
Douglas B. Kell, M. Asad Khan, Resia Pretorius |
| 8 |
[GO] |
2024―Jul―26 |
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs. no anticoagulation: Final analysis of the OVID randomized trial |
Riccardo M. Fumagalli, Davide Voci, Behnood Bikdeli, Roland Bingisser, Giuseppe Colucci, Gabor Forgo, Teresa Gerardi, Bernhard Gerber, Alexandru Grigorean, Frederikus A. Klok, Marc Righini, Helia Robert-Ebadi, Stefan Stortecky, Silvia Ulrich, Simon Wolf, Dörte Wyss, Lukas Hobohm, Nils Kucher, Stefano Barco, Stefano Barco, Davide Voci, Ulrike Held, Tim Sebastian, Roland Bingisser, Giuseppe Colucci, Daniel Duerschmied, André Frenk, Bernhard Gerber, Andrea Götschi, Stavros V. Konstantinides, François Mach, Helia Robert-Ebadi, Thomas Rosemann, Noemi R. Simon, Hervé Spechbach, David Spirk, Stefan Stortecky, Lukas Vaisnora, Marc Righini, Nils Kucher, Stéphanie Roth Zetzsche, Rebecca Spescha, Claudia Leeger, Yulia Butscheid, Eliane Probst, Evy Micieli, Gabor Forgo, Fabian Johner, Alexandru Grigorean, Georgios Vatsakis, Dagmar Keller Lang, Silvana Rampini Speck, Barbara Hasse, Marco Rueegg, Isabelle Arnold, Christian Nickel, Jeannette Busch, Marc Blondon, Frédéric Glauser, Micol G. Cittone, Chiara Kessler, Diona Gjermeni, Christoph B. Olivier, Nadine Gauchel, Paul Biever, Lukas Hobohm, Dorothea Becker, Marc Schindewolf, Arnaud Kuenzi, Silvia Ulrich |
| 9 |
[GO] |
2024―Apr―24 |
High risk subgroups were not identified to benefit from thromboprophylaxis after hospitalization for COVID-19 |
Lisa Baumann Kreuziger, Taeim Kwon, Raj S. Kasthuri, Lana Wahid, Peter J. Miller, Kimberly Enders, Abdus S. Wahed, Kevin J. Anstrom, Tracy Y. Wang, Thomas L. Ortel |
| 10 |
[GO] |
2024―Apr―24 |
Coagulation and inflammatory response after intramuscular or intradermal mRNA-1273 SARS-CoV-2 vaccine - secondary analysis of a randomized trial |
Willian J. van Dijk, Margaretha L.M. Prins, Anna H.E. Roukens, Geert V.T. Roozen, Meta Roestenberg, Leo G. Visser, Astrid van Hylckama Vlieg, Frits R. Rosendaal |
| 11 |
[GO] |
2024―Mar―15 |
In vitro effect of hydroxyethyl starch on COVID-19 patients associated hypofibrinolytic state |
Hamdi Rezigue, Michel Hanss, Jean-Stéphane David, Yesim Dargaud, Christophe Nougier |
| 12 |
[GO] |
2024―Mar―01 |
Thrombocytopenia with and without thrombosis following COVID-19 vaccination: long-term management |
M. Ge, D. Ladha, J. Lymer, S. Pancic, M. Carrier, G. Le Gal, L.A. Castellucci |
| 13 |
[GO] |
2024―Feb―05 |
Hematologic Characteristics and Coagulopathy in Pregnancy with COVID-19 S쳮ding The First Wave: A Multicenter Retrospective Cross-Sectional Study |
Maha Othman, Georgiana Nemeti, Marissa Solow, Gheorghe Cruciat, Daniel Muresan, Mariam Suzana Chaikh Sulaiman, Shivani Thaker, Rezan Abdul-Kadir, A. Kinga Malinowski |
| 14 |
[GO] |
2024―Jan―21 |
PB1184 Monitoring of Low Molecular Weight Heparin by Thrombodynamics Analyser System (TD T2 T) in Intensive Care Patients with COVID-19 Infection |
A. Riddell, P. Panagiotidis, A. Drebes, P. Batty, P. Chowdary, G. Getti |
| 15 |
[GO] |
2023―Dec―07 |
Coagulopathy and adverse outcomes in hospitalized COVID-19: Results from the NOR-Solidarity trial |
Thor Ueland, Annika E. Michelsen, Anders Aune Tveita, Trine Kåsine, Tuva B. Dahl, Ane-Kristine Finbråten, Aleksander R. Holten, Ole Henning Skjønsberg, Alexander Mathiessen, Katerina N. Henriksen, Marius Trøseid, Trond Mogens Aaløkken, Bente Halvorsen, Anne Ma Dyrhol-Riise, Andreas Barratt-Due, Pål Aukrust |
| 16 |
[GO] |
2023―Nov―14 |
Breakthrough infections after COVID-19 vaccinations do not elicit platelet hyper-activation and associate with high platelet-lymphocyte and low platelet-neutrophil aggregates |
Francesca Maiorca, Ludovica Lombardi, Ramona Marrapodi, Davide Pallucci, Annamaria Sabetta, Maria Antonella Zingaropoli, Valentina Perri, Davide Flego, Giulio Francesco Romiti, Bernadette Corica, Marzia Miglionico, Gianluca Russo, Patrizia Pasculli, Maria Rosa Ciardi, Claudio M. Mastroianni, Franco Ruberto, Francesco Pugliese, Fabio Pulcinelli, Valeria Raparelli, Roberto Cangemi, Marcella Visentini, Stefania Basili, Lucia Stefanini |
| 17 |
[GO] |
2023―Nov―11 |
PO06 Blood Count Abnormalities in Coronavirus Infection 2019 (COVID-19) |
A. Nabila |
| 18 |
[GO] |
2023―Nov―11 |
PB1070 Small and Large Extracellular Vesicles have Different Tissue Factor Activity in Cancer, Sepsis, and COVID-19 |
A. Sachetto, S. Archibald, Y. Hisada, A. Rosell, S. Havervall, N. van Es, R. Nieuwland, R. Campbell, E. Middleton, M. Rondina, C. Thålin, N. Mackman |
| 19 |
[GO] |
2023―Nov―11 |
PB0604 The VWF-ADAMTS13 Axis as Biomarkers of Disease Progression in Severe COVID-19 |
M. Hinds, M. Bowman, J. Grabell, C. Yeh, P. Gross, A. Fox-Robichaud, P. Kim, D. Lillicrap, P. James |
| 20 |
[GO] |
2023―Nov―11 |
PB0601 Identification of a Novel Growth Factor-Enriched Platelet Subpopulation: Potential Implications for COVID-19 |
A. Asgari, P. Jurasz |
| 21 |
[GO] |
2023―Nov―11 |
PB0115 Paxlovid Attenuates the Inflammatory and Thrombotic Response in High-Risk Patients with COVID-19 |
L. Del Carpio-Orantes, S. Hernández-Hernández, A. Aguilar-Silva, A. Rosas-Lozano, S. García-Méndez, J. Sánchez-Díaz, R. Salazar-Lizárraga, R. Domínguez-Cámara |
| 22 |
[GO] |
2023―Nov―11 |
PB0107 The Relationship between Length of Hospital Stay and Anticoagulant Use in Patients with Moderate COVID-19 |
P. Lasut, R. Cikutra, L. Rotty, H. Haroen, C. Hendratta, R. Rattu, E. Polii |
| 23 |
[GO] |
2023―Nov―11 |
PB0103 Disturbance of the Hemostatic Balance in Outpatients with Covid-19 |
M. Iglesias Varela, M. Siracusa, L. Donlo |
| 24 |
[GO] |
2023―Nov―11 |
PB0093 Antiphospholipid Antibodies in Convalescent Plasma of Donors Recovered from Mild COVID-19 |
D. Blickstein, M. Izak, T. Filipovich-Rimon, O. Garach-Jehoshua, N. Rahimi-Levene, E. Shinar, R. Abu Hamad, A. Bar-Chaim, M. Koren-Michowitz |
| 25 |
[GO] |
2023―Nov―11 |
PB0091 Fibrin Monomers Positivity During Hospitalization is a Good Predictive Marker of In-Hospital Mortality during COVID-19 |
D. Smadja, N. Gendron, A. Philippe, J. Diehl, N. Ochat, O. Bory, A. Beauvais, A. Mareau, A. Jannot, R. Chocron |
| 26 |
[GO] |
2023―Nov―11 |
PB0077 Predictors of Mortality in Hospitalized Patients with COVID-19 |
M. Chindamo, F. Pozzobon, G. Sardinha, A. Marques, H. Goudar, A. Nunes, P. Carmo, D. Salgado |
| 27 |
[GO] |
2023―Nov―11 |
PB0069 Risk Factors for Venous Thromboembolism in Patients Hospitalized with COVID-19 |
M. Chindamo, G. Sardinha, A. Marques, H. Goudar, A. Nunes, P. Carmo, D. Salgado |
| 28 |
[GO] |
2023―Nov―11 |
PB0051 Persistent Elevation of ɣ’ Fibrinogen in Acute and Convalescent COVID-19 |
H. Fogarty, G. Gilmore, J. O’Donnell, D. Farrell, J. Tiao, R. Baker |
| 29 |
[GO] |
2023―Nov―11 |
OC 29.2 The Impact of Pulmonary Embolism on the Long-Term Health Outcomes of COVID-19 |
C. Visser, J. Berentschot, C. De Jong, M. Antoni, R. Berg-Emons, B. Borst, H. ten Cate, A. ten Cate-Hoek, D. Braeken, J. Geelhoed, M. Heijenbrok-Kal, L. Kroft, J. Leentjens, A. Roukens, S. Cannegieter, E. Klok, M. Hellemons, M. Kruip |
| 30 |
[GO] |
2023―Nov―11 |
PO07 Is Covid-19 a Trigger Factor for Thrombotic Complications in Late Pregnancy? |
V. Popov, B. Mastalier, L. Iliescu, M. Andreescu |
| 31 |
[GO] |
2023―Nov―11 |
PB0066 Features of Functioning of the ADAMTS-13/vWF Axis in Pregnant Women with Covid-19 and after Infection during Pregnancy |
N. Gashimova, G. Kristina, V. Bitsadze, L. Pankratyeva, J. Khizroeva, R. Atadzhanova, M. Pozhidaeva, N. Makatsariya, A. Makatsariya |
| 32 |
[GO] |
2023―Nov―11 |
PB0071 The Impact of COVID-19 and Venovenous ECMO on the Generation and Characteristics of Extracellular Vesicles |
L. Traby, L. Eischer, M. Kollars, M. Kussmann, N. Buchtele, M. Weiss-Tessbach, T. Staudinger, H. Burgmann, O. Robak, P. Kyrle, S. Eichinger |
| 33 |
[GO] |
2023―Nov―11 |
OC 29.1 Long-Term Outcomes of COVID-19 Associated Venous Thromboembolism (VTE) |
W. Ageno, E. Antonucci, D. Poli, E. Bucherini, A. Chistolini, V. Fregoni, T. Lerede, R. Pancani, S. Pedrini, F. Pieralli, P. Pignatelli, A. Pizzini, G. Podda, N. Potere, L. Sarti, S. Testa, A. Visonà, G. Palareti |
| 34 |
[GO] |
2023―Nov―11 |
PB1338 Thrombotic Thrombocytopenia Syndrome after vaccination against COVID-19 Associated with Antiplatelet Antibodies |
T. Thiele, M. Esefeld, S. Handtke, J. Rath, L. Schönborn, J. Antovich, K. Lotfi, M. Holmström, L. Harasser, C. Feistritzer, L. Loacker, T. Hoffmann, S. Wunderlich, A. Greinacher |
| 35 |
[GO] |
2023―Nov―11 |
PB0056 Predicting VTE and Mortality in COVID-19 by Receiver-Operating Characteristic (ROC) Analysis of Haemostatic and Inflammatory Biomarkers |
M. Peralta, V. Muczynski, P. Lane, L. Pagala, A. Riddell, S. Bhagani, B. Agarwal, A. Drebes, J. McVey, T. Kotecha, D. Hughes, D. Martin, A. Davenport, T. Sood, L. Lanning, T. Gandhi, P. Chowdary |
| 36 |
[GO] |
2023―Nov―11 |
PB0104 Emergency Mobile and Point of Care Anticoagulation Clinic During (COVID-19) Curfew by Pharmacists in Saudi Arabia |
F. Alayoubi, A. Al Shaban, I. Elnahal |
| 37 |
[GO] |
2023―Nov―11 |
PB0600 Circulating Platelet-Derived Extracellular Vesicles are Increased in Severe COVID-19 Disease |
T. Helin, M. Palviainen, M. Lemponen, K. Maaninka, P. Siljander, L. Joutsi-Korhonen |
| 38 |
[GO] |
2023―Nov―11 |
PB0096 Cytokines Profile of Severe COVID-19 does not Differ from ICU-Control |
M. Peralta, B. Newell, V. Muczynski, P. Lane, L. Pagala, D. Hughes, A. Riddell, S. Bhagani, B. Agarwal, A. Drebes, J. McVey, T. Kotecha, D. Martin, A. Davenport, T. Sood, L. Lanning, T. Gandhi, P. Chowdary |
| 39 |
[GO] |
2023―Nov―11 |
PB0085 Pitfalls of Complications due to Coagulopathy in Patients with Severe COVID-19 during ECMO: Beware of Bleeding Caused by Acquired von Willebrand Syndrome |
H. Ishikura, Y. Irie, K. Muranishi, J. Maruyama, M. Nakashio, Y. Okura, S. Morimoto, Y. Izutani, Y. Nakamura |
| 40 |
[GO] |
2023―Nov―11 |
OC 32.3 Age, Race, D-Dimer, and Modified IMPROVE VTE Score did not Predict Effect of Thromboprophylaxis on Arterial Thromboembolism, Venous Thromboembolism, or Death after COVID-19 Hospitalization |
L. Baumann Kreuziger, A. Wahed, K. Anstrom, T. Wang, T. Ortel |
| 41 |
[GO] |
2023―Nov―11 |
OC 29.5 Outcomes of COVID-19 in Persons with Hemophilia: A Propensity ScoreMatched Cohort Study froma US-BasedNational COVIDRegistry |
A. Sharathkumar, L. Wendt, C. Ortman, E. Chrischilles, C. Takemoto |
| 42 |
[GO] |
2023―Nov―11 |
PB0054 Impact of Variations in Sex Hormone Levels on the Hypercoagulability and Severity of COVID-19 in Women and Men According to Age. The ROADMAP-COVID-19 Study |
P. Van Dreden, M. Sabbah, M. Grussé, A. Rousseau, L. Louadj, G. Gerotziafas |
| 43 |
[GO] |
2023―Nov―11 |
PB0138 COVID-19 Induces miRNA Changes-ACE-2 Related Network: In Silico, Machine Learning and Validation Analysis |
Z. Wicik, C. Eyileten, A. Nowak, D. Keshwani, M. Marszałek, S. Simões, D. Martins, J. Siller-Matula, M. Potuła |
| 44 |
[GO] |
2023―Nov―11 |
PB1306 Inhibitor Recurrence Following Immune Tolerance Induction in a Hemophilia A Patient with Inhibitor Post COVID-19 Infection |
S. Cheng, L. Wang, J. Yu |
| 45 |
[GO] |
2023―Nov―11 |
PB0072 Thrombin Generation Potential and the Risk of Severe COVID-19 Infection |
W. van Dijk, K. Föhse, M. Netea, H. van Werkhoven, M. Bonten, M. Grobusch, M. van den Bosch, F. Rosendaal, A. van Hylckama Vlieg |
| 46 |
[GO] |
2023―Nov―11 |
PB0047 COVID-19 Infection-Associated Platelet and Neutrophil Activation is Blunted by Previous Anti-SARS-CoV-2 Vaccination |
E. Petito, L. Franco, E. Falcinelli, G. Guglielmini, C. Conti, F. Tondi, G. Vaudo, U. Paliani, C. Becattini, P. Gresele |
| 47 |
[GO] |
2023―Nov―11 |
PB0613 IL-6 Dosage by ELISA Tests in Patients after COVID-19 Infection: Significant Correlation between Length of Hospitalization and Permanently Altered Levels of Interleukin-6 |
A. Prezotti, D. Campos da Silva, H. Vitória, A. Zetum, H. Rosa, V. Ventorim, E. Vargas, L. Alves, R. Netto, D. Meira, M. Casotti, R. Reis, S. Marcondes, D. Rocha, A. Rocha-Neto, N. Santos, J. Duarte, M. Orletti, L. Resende, I. Louro |
| 48 |
[GO] |
2023―Nov―11 |
PB0049 Thromboprophylaxis with Enoxaparin for Symptomatic COVID-19 Managed in the Ambulatory Setting: Pooled Analysis of the OVID and ETHIC Trials |
S. Barco, S. Virdone, F. Cools, R. Fumagalli, A. Götschi, G. Kayani, N. Kucher, K. Pieper, D. Voci, U. Held, A. Kakkar |
| 49 |
[GO] |
2023―Nov―11 |
PB0100 Anticoagulation in Hospitalized COVID-19 Obese Patients and Venous Thromboembolism (VTE) in Salvador - Brazil |
A. Rocha, L. Zanatta, J. Gomes, J. De Oliveira, R. Ferreira, L. Ritt |
| 50 |
[GO] |
2023―Nov―11 |
PB0022 Impact of COVID-19 on Thromboembolic Events and Mortality among Patients with Non-Valvular Atrial Fibrillation Receiving Oral Anticoagulants |
I. Hernandez, A. Dhamane, X. Liu, N. Atreja, S. Han, Q. Zhang, T. Lokhandwala, X. Sun, X. Luo |
| 51 |
[GO] |
2023―Nov―11 |
PB0282 Evaluation of Plasma Coagulative and Fibrinolytic Function in Critically Ill Children with COVID-19 or MIS-C An Analysis of the COVAC-TP Trial |
A. Sellers, S. Bruzek, E. Amankwah, V. Ignjatovic, M. Betensky, N. Goldenberg, A. Sochet |
| 52 |
[GO] |
2023―Nov―11 |
PB0469 Frequency of INR Monitoring and Their Impact on INR Control during the COVID-19 Pandemic |
T. Elling, N. Veeger, D. Hardeman, A. Kruit, J. Pouwels, V. Tichelaar, K. Meijer |
| 53 |
[GO] |
2023―Nov―11 |
PB0074 Hyper-Immunoglobulin-CovImmuneTM, Provides a Broader Coverage Against Diverse SARS-CoV-2 Variants Relevant to the COVID-19 Pandemic |
L. Rozen, C. Maoudis, J. Foster, S. Turville, T. Kelleher, S. Mahler, H. Nair |
| 54 |
[GO] |
2023―Nov―11 |
PB1225 Acquired Haemophilia in the COVID-19 Pandemic Era - Does Vaccination or Infection Increase its Risk and Influence Outcomes? |
A. Chia, M. Cheong, W. Wong, C. Tan, H. Kaur, S. Tien, L. Lee, H. Ng, Y. Tan |
| 55 |
[GO] |
2023―Nov―11 |
PB0080 The Effect of COVID-19 Pandemic in Haemophilia Patients in Argentina |
M. Martinez, M. Williams, D. Neme, S. Borchichi, G. Sliba, H. Caferri, S. Garbiero, S. Risso Patron L, M. Cruz, M. Costa, M. Cedola, V. canonico, M. Arrieta, V. Galdeano, V. Listello, M. Lopez, D. Morell, M. Torresi, B. Brunori L, R. Quinteros |
| 56 |
[GO] |
2023―Nov―11 |
PB0326 Incidence of Thrombotic Thrombocytopenic Purpura and Other Suspected Thrombotic Microangiopathies during the COVID-19 Pandemic Period 2020-2021 in Q |
C. Merlen, E. Pépin, S. Thouzeau, G. Rivard, S. Troyanov, A. Bonnefoy |
| 57 |
[GO] |
2023―Nov―11 |
PB0774 The Role of Immunothrombosis in Acute Coronary Syndrome (ACS) Patients during COVID-19 Pandemic: Analysis during a 2 Year Follow-Up |
P. Gomez Rosas, M. Marchetti, L. Pescetelli, E. Sanga, L. Russo, S. Gamba, C. Verzeroli, D. Pellegrini, L. Fiocca, P. Canova, A. Vassileva, F. Moretti, A. Grosu, G. Guagliumi, A. Falanga |
| 58 |
[GO] |
2023―Nov―11 |
PO05 Challenges with Warfarin Management in COVID-19 Patients |
C. Choo, K. Kng, K. Ong, E. Goh, B. Fan, N. Pandit |
| 59 |
[GO] |
2023―Nov―11 |
PB0101 Comparison of Padua Prediction Score and IMPROVE VTE Risk Score for Venous Thromboembolism at Admission to Assess Hypercoagulation in COVID-19 Patients |
P. Lasut, A. Hukom, V. Irawan, J. Arifputra, L. Rotty, H. Haroen, C. Hendratta |
| 60 |
[GO] |
2023―Nov―11 |
PB0094 Antiphospholipid Antibodies in Severe and Critically ill COVID-19 Patients |
J. Khizroeva, A. Makatsariya, V. Bitsadze, M. Tretyakova, A. Solopova, A. Vorobev, A. Mischenko, B. Baldansambuu, D. Doronicheva, G. Kristina, N. Gashimova, D. Zabolotnaya, D. Blbulyan, K. Khalieva |
| 61 |
[GO] |
2023―Nov―11 |
PB0097 Intracellular Nuclear Proteins Histone H3 and HMGB1 are Predictive Markers of Disease Severity and Prognosis of COVID-19 Patients |
K. Hayashi, D. Koyama, Y. Hamazak, T. Kamiyama, S. Yamada, Y. Tanino, Y. Shibata, T. Ikezoe |
| 62 |
[GO] |
2023―Nov―11 |
PB0083 Efficacy and Safety of Thromboprophylaxis in Covid-19 Patients |
W. Maneechot, R. Lamool |
| 63 |
[GO] |
2023―Nov―11 |
PB0081 von Willebrand Factor and Myeloperoxidase as Laboratory Predictive Markers of In-Hospital Survival in Severe COVID-19 Patients |
A. Makatsariya, V. Bitsadze, J. Khizroeva, L. Pankratyeva, J. Gris, I. Elalamy, M. Tretyakova, G. Kristina, Z. Aslanova, N. Gashimova, I. Nakaidze, D. Zabolotnaya, A. Pervushina, D. Blbulyan, A. Lazarchuk, P. Salnikova |
| 64 |
[GO] |
2023―Nov―11 |
PB0059 Thrombomodulin Resistance as a Novel Pathway Involved in the Hypercoagulable State of COVID-19 Patients |
A. Montaño, A. Marco, F. López Jaime, I. Fernández-Bello, P. Marco Vera |
| 65 |
[GO] |
2023―Nov―11 |
PB0055 Influence of Argatroban on Fibrinolysis ex-vivo in Blood Samples of Healthy Volunteers and in-vivo in Critically ill COVID-19 Patients |
M. Bachler, A. Tobiasch, J. Bösch, K. Pezzi, D. Niederbrunner, R. Kammerlander, V. Schäfer, M. Joannidis, D. Fries |
| 66 |
[GO] |
2023―Nov―11 |
PB0046 Increased Platelet Activation Demonstrated by Elevated CD36 and P-Selectin Expression in 1-year Post Recovered COVID-19 Patients |
S. Wang, K. Chee, S. Wong, G. Tan, H. Ang, B. Leung, C. Tan, K. Ramanathan, R. Dalan, C. Cheung, D. Lye, B. Young, E. Yap, Y. Chia, B. Fan |
| 67 |
[GO] |
2023―Nov―11 |
OC 55.1 Balance between Neutrophil Extracellular Trap Formation and DNase Activity in COVID-19 Patients |
G. Garcia, S. Labrouche-Colomer, A. Duvignaud, E. Clequin, C. Dussiau, D. Tregouet, D. Malvy, R. Prével, J. Goret, M. Mamani-Matsuda, A. Dewitte, C. James |
| 68 |
[GO] |
2023―Nov―11 |
OC 05.4 Defective Nitric Oxide Production and Increased Reactive Oxygen Species Generation by Platelets from COVID-19 Patients |
E. Petito, G. Guglielmini, E. De Robertis, E. Giglio, C. Becattini, E. Falcinelli, L. Franco, F. Tondi, F. Gori, G. Vaudo, V. Cerotto, U. Paliani, P. Gresele |
| 69 |
[GO] |
2023―Nov―11 |
PB0082 VTE Incidence and Risk Factors among Hospitalized COVID-19 Patients in Salvador -Brazil |
A. Rocha, R. Ferreira, L. Zanatta, J. De Oliveira, J. Gomes, L. Ritt |
| 70 |
[GO] |
2023―Nov―11 |
PB0079 Severity of Pulmonary Embolism among Hospitalized COVID-19 Patients in Salvador-Brazil |
A. Rocha, J. De Oliveira, L. Zanatta, R. Ferreira, J. Gomes, L. Ritt |
| 71 |
[GO] |
2023―Nov―11 |
PB0073 A Retrospective Study of Two Anticoagulation Therapies In Critically Ill Covid-19 Patients Prior to Vaccination Era |
R. Costa-Filho, A. Oliveira, E. Furtado, F. Saddy, R. de Souza, M. Azevedo, D. Cerqueira, V. Gualberto, J. Costa, H. Castro-Faria-Neto |
| 72 |
[GO] |
2023―Nov―11 |
PB0602 Plasma NET Markers Kinetics in COVID-19 Patients Receiving Immunomodulatory Treatments |
G. Garcia, A. Dewitte, S. Labrouche-Colomer, C. Mouton, C. Delassasseigne, F. Ménard, C. Vinclair, E. Begot, L. Petit, C. Carrié, D. Malvy, A. Duvignaud, C. James, R. Prével |
| 73 |
[GO] |
2023―Nov―11 |
PB0065 Targeting the Endothelium when Treating Convalescent COVID-19 Patients, the Effect on Serum Biomarkers, and Post-COVID Functional Status. Midterm Results of a Randomized, Placebo-Controlled Trial |
A. Gonzalez Ochoa, A. Hernandez, J. Fareed |
| 74 |
[GO] |
2023―Nov―11 |
PB0063 IMPROVE-DD Score among Hospitalized COVID-19 Patients to Predict Post-Discharge VTE Prophylaxis |
A. Rocha, R. Ferreira, L. Zanatta, J. Gomes, J. De Oliveira, L. Ritt |
| 75 |
[GO] |
2023―Nov―11 |
PB0089 Anticoagulants after COVID-19 Pneumonia for Patients with Low Thrombotic Risk |
T. Pertseva, L. Konopkina, N. Habshydze, L. Botvinikova, O. Myronenko |
| 76 |
[GO] |
2023―Nov―11 |
PB0067 Prognostic Value of the ISTH DIC Scoring System in Prediction of 28-Day Mortality in Hospitalized COVID-19 Pneumonia Patients |
T. Thamgrang, P. Silpsamrit, R. Lamool, K. Prayongratana |
| 77 |
[GO] |
2023―Nov―11 |
OC 29.3 CD147 Plasma Levels in Hospitalised Patients with Covid-19 Pneumonia Predict Illness Severity and In-Hospital Mortality |
D. Smadja, A. Philippe, E. Campos, R. Oliveira, C. Mccabe, L. Zhao |
| 78 |
[GO] |
2023―Nov―11 |
OC 05.5 Hemostatic Biomarkers in Long-Covid Syndrome: A Cross-Sectional Study of 1,310 Covid-19 Survivors |
C. Ambaglio, S. Benatti, C. Tartari, C. Giaccherini, L. Russo, S. Gamba, S. Bolognini, C. Ticozzi, C. Verzeroli, F. Schieppati, V. Brusegan, S. Venturelli, L. Barcella, M. Rizzi, M. Marchetti, A. Falanga |
| 79 |
[GO] |
2023―Nov―11 |
PB0064 Involvement of Platelet Activation in Long COVID-19 Syndrome |
M. Brambilla, M. Conti, A. Becchetti, P. Canzano, P. Agostoni, M. Pengo, E. Tortorici, M. Mancini, D. Andreini, A. Bonomi, G. Parati, M. Camera |
| 80 |
[GO] |
2023―Nov―11 |
PB0050 Heparin Concentrations in Pediatric Patients with Paediatric Inflammatory Multisystem Syndrome Associated with COVID-19. The Measurement Importance in the Inflammatory State |
M. Nuñez Toscano, L. Valderrama Orenday, N. Lopez Santiago, R. Paredes Aguilera, M. Gonzalez Pedroza |
| 81 |
[GO] |
2023―Nov―11 |
PB1100 Effects of COVID-19 Vaccination on Pro-Coagulant State of a Protein S-Deficient Pediatric Patient: New Hope for Treatment of the Deficiency |
D. Polania-Villanueva, M. Kumar, L. Thangada, J. Garai, J. Zabaleta, R. Majumder |
| 82 |
[GO] |
2023―Nov―11 |
PB0266 Effect of COVID-19 Vaccine or Infection on Pediatric Patients with Current or Prior Immune Thrombocytopenia |
W. Chue, N. Binte Abdul Kadir, J. Lam |
| 83 |
[GO] |
2023―Nov―11 |
OC 76.5 Head-to-head Comparison of Four COVID-19 Vaccines on Platelet Activation, Coagulation and Inflammation. the TREASURE Study |
M. Brambilla, P. Della Valle, A. Becchetti, M. Conti, P. Canzano, M. Alberti, A. Galotta, M. Biondi, A. Bonomi, N. Cosentino, D. Armando, M. Camera |
| 84 |
[GO] |
2023―Nov―11 |
OC 05.3 Incidence and Risk Factors for Venous Thromboembolism in Hospitalized Patients Across Three Major COVID-19 Variants in an Asian Cohort |
S. Lee, W. Teo, C. Lim, W. Jen, C. Lee, E. Yap, Y. Chee |
| 85 |
[GO] |
2023―Nov―11 |
OC 22.2 Endothelial Activation and Von Willebrand Factor Role in COVID-19- Associated Coagulopathy |
R. Aiolfi, H. Deguchi, J. Fernández, J. Ahmed, M. Hauer-Jensen, S. Kanaji, Z. Ruggeri, J. de la Torre, L. Mosnier |
| 86 |
[GO] |
2023―Nov―11 |
OC 01.4 Prevalence of Chronic Thromboembolic Pulmonary Hypertension and Evaluation of Thrombus Resolution in COVID-19-Associated Pulmonary Embolism Survivors |
C. De Jong, C. Visser, M. Kruip, E. Klok |
| 87 |
[GO] |
2023―Nov―11 |
LB 01.5 Effect of the P-selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial |
C. Lowenstein, S. Solomon, A. Bhatt, A. Peikert, O. Vardeny, M. Kosiborod, J. Berger, H. Reynolds, A. Althouse, E. Leifer, A. Kindzelski, M. Cushman, M. Gong, L. Kornblith, K. Kim, L. Baumann Kreuziger, B. Kirwan, M. Geraci, M. Neal, J. Hochman |
| 88 |
[GO] |
2023―Nov―11 |
PB0612 COVID-19: Predictive Value of Methemoglobinemia |
H. Hadjer, B. Mouna Rajaa, B. Bouchra, B. Adel, G. Faiza, M. Najdette, L. Houcine, S. Abdi |
| 89 |
[GO] |
2023―Nov―11 |
PB0052 Heparin Type & Clinical Outcomes in Hospitalized, Non-Critically Ill Patients with COVID-19: Secondary Analysis of an International Multi-Platform RCT |
Q. Tays, B. Houston, W. Teng, R. Balshaw, P. Lawler, S. Lother, A. Garland, A. Mendelson, E. Rimmer, D. Houston, M. Neal, M. Farkouh, M. Carrier, E. Goligher, L. Castellucci, R. Ariano, J. Falk, A. Heath, R. Zarychanski |
| 90 |
[GO] |
2023―Nov―11 |
OC 29.4 Impact of Symptom Duration on Clinical Outcomes in Hospitalized, Non-Critically Ill Patients with COVID-19; Secondary Analysis of an International Multi-Platform RCT |
Q. Tays, W. Teng, B. Houston, R. Balshaw, P. Lawler, S. Lother, A. Garland, A. Mendelson, E. Rimmer, D. Houston, M. Neal, M. Farkouh, M. Carrier, E. Goligher, L. Castellucci, J. Falk, R. Ariano, A. Heath, R. Zarychanski |
| 91 |
[GO] |
2023―Nov―11 |
OC 05.2 Impact of Heparin on Disease State Transition in Hospitalized, Non-Critically Ill Patients with COVID-19; Secondary Analysis of an International Multi-Platform RCT |
Q. Tays, B. Houston, W. Teng, R. Balshaw, P. Lawler, S. Lother, A. Garland, A. Mendelson, E. Rimmer, D. Houston, M. Neal, M. Farkouh, M. Carrier, E. Goligher, L. Castellucci, R. Ariano, J. Falk, A. Heath, R. Zarychanski |
| 92 |
[GO] |
2023―Nov―11 |
PB0114 Human Immunodeficiency Virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2): Dangerous Liaisons? |
S. Louw, B. Jacobson, E. Mayne |
| 93 |
[GO] |
2023―Nov―11 |
PB0768 Mouse Strain Specific Response to a Murine Coronavirus Respiratory Infection |
P. Gibler, L. Boccuni, M. Salzmann, J. Pointner, R. Plasenzotti, J. Wojta, B. Podesser, P. Hohensinner |
| 94 |
[GO] |
2023―Nov―11 |
PB0076 Platelet Activation and Cytokine Release of Interleukin-8 and IP-10 after ChAdOx1 nCoV-19 Coronavirus Vaccine Injection |
Y. Wu, C. Shen, T. Wang, C. Liu |
| 95 |
[GO] |
2023―Nov―11 |
OC 22.5 Effect of Angiostatin and its Neutralization on Cellular Infection by SARS-CoV and SARS-CoV-2 |
A. Franczak, M. Joyce, M. Saito, L. Tyrrell, P. Jurasz |
| 96 |
[GO] |
2023―Nov―11 |
PB0772 Platelet-B Cell Interactions Modulate the Antibody Response to Adenoviral and mRNA Vaccines against SARS-CoV-2 |
D. Pallucci, L. Lombardi, F. Maiorca, R. Marrapodi, A. Sabetta, N. Scafa, M. Miglionico, G. Romiti, B. Corica, S. Piconese, F. Pulcinelli, R. Cangemi, M. Visentini, S. Basili, L. Stefanini |
| 97 |
[GO] |
2023―Nov―11 |
PB0084 Incidences of Adverse Effects of Vaccination against SARS-CoV-2 in Patients with Congenital Coagulopathies |
B. Diaz Jordan |
| 98 |
[GO] |
2023―Nov―11 |
OC 22.1 Proteome and Phosphoproteome Analyses of SARS-CoV-2 Infected Humanized ACE2 Mice Platelets Revealed Reprogramming of Platelets from Early Hyperreactive to Late Antiviral Phenotypes |
S. Subramaniam, R. Hekman, A. Jayaraman, D. Kenney, A. Kateri O’Connell, P. Montanaro, B. Blum, S. Walachowski, M. Ericsson, K. Ravid, N. A. Crossland, A. Emili, F. Douam, M. Bosmann |
| 99 |
[GO] |
2023―Nov―11 |
PB0087 Use of Viscoelastic Tests in the Intensive Care Unit for the Evaluation of Haemostasis in SARS-COV-2 Infection |
T. Sevivas, I. Santos, J. Alves, J. Luzio, J. Pego, F. Caramelo, A. Paiva, P. Martins |
| 100 |
[GO] |
2023―Nov―11 |
PB0599 Dysregulation of Annexin A2 System Triggered by Acute SARS-CoV-2 Infection in Human ACE2 Transgenic Mice |
A. Drelich, P. Saenkham-Huntsinger, B. Judy, P. Huang, P. Bi-Hung, T. Ksiazek, C. Tseng |
| 101 |
[GO] |
2023―Nov―11 |
PB0062 Extracellular Vesicles as Markers of Inflammation and Hypercoagulability during the First Month of Sars-COV-2 Infection in Outpatients and Hospitalized Patients |
B. Barion, T. Rocha, P. Villaça, H. Yeh Li, B. Mazetto, E. Okazaki, C. Rothschild, B. Stefanello, V. Rocha, F. Orsi |
| 102 |
[GO] |
2023―Nov―11 |
PB0057 SARS-CoV-2 Infection Results in Upregulation of PAI-1 and Neuroserpin in the Lungs, and an Increase in Fibrinolysis Inhibitors Associated with Disease Severity |
K. Toomer, G. Gerber, Y. Zhang, L. Daou, M. Tushek, J. Hooper, I. Francischetti |
| 103 |
[GO] |
2023―Nov―11 |
OC 76.4 Elevation of Antiphospholipid Antibody Titers Following Vaccination with SARS-CoV-2 mRNA in Patients with Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus |
M. Yasuda, Y. Fujieda, K. Sakiyama, M. Tada, H. Moriya, J. Wei, R. Hisada, M. Kono, M. Kato, O. Amengual, A. Yasumoto, E. Morishita, T. Urano, T. Atsumi |
| 104 |
[GO] |
2023―Nov―11 |
PB0060 Thrombosis in Greek Children Before and After SARS-CoV-2 Outbreak: A Single Centre Experience |
A. Dettoraki, L. Ioannidou, A. Michalopoulou, N. Papageorgiou, S. Saslis, I. Stamati, H. Karelioti, Z. Kapsimali, C. Kanaka-gantenbein, H. Pergantou |
| 105 |
[GO] |
2023―Nov―11 |
OC 22.4 SARS-CoV-2 Protein ORF3a Promotes Release of Procoagulant Tissue Factor-Positive Extracellular Vesicles |
S. Ansari, J. Ludington, K. Enjyoji, P. Anderson, G. Oliveira Junior, I. Ghiran, R. Schwartz, A. Schmaier, S. Schulman |
| 106 |
[GO] |
2023―Nov―11 |
OC 22.3 Monocytes and Macrophages Promote Increased Tissue Factor/Factor VIIa-Dependent Procoagulant Activity in Response to the SARS-CoV-2 Spike Protein |
J. Harte, C. Coleman-Vaughan, J. McCarthy, M. Crowley, V. Mykytiv |
| 107 |
[GO] |
2023―Nov―11 |
PB0607 Evaluation of Proinflammatory and Haemostasis Markers after BNT162b2 SARS-CoV-2 Vaccination |
I. Ivanko, I. Celap, S. Margetic, D. Marijančević, A. Vahtarić, J. Josipovic, P. Gaćina |
| 108 |
[GO] |
2023―Nov―11 |
PB0349 Anti-PF4-Antibodies in Patients Suspected of Vaccine-Induced Immune Thrombotic Thrombocytopenia After SARS-CoV-2 Vaccination |
G. Uzun, K. Althaus, S. Hammer, T. Bakchoul |
| 109 |
[GO] |
2023―Nov―11 |
OC 76.3 SARS-CoV-2 Vaccination and Risk of Venous Thrombosis - Case Control Study on Routine Care Data from Dutch General Practitioners |
W. van Dijk, S. Hugten, F. Rosendaal, A. Van Hylckama Vlieg |
| 110 |
[GO] |
2023―Nov―11 |
PB0088 Alterations in Thrombin Generation after SARS-CoV-2 Vaccination and the Relation with Inflammation |
W. van Dijk, M. Prins, A. van Hylckama Vlieg, L. Visser, F. Rosendaal |
| 111 |
[GO] |
2023―Nov―11 |
PO04 SARS-CoV-2 Vaccinations and Risk of Venous Thrombosis - Case Control Study |
W. van Dijk, A. Kant, F. Rosendaal, A. van Hylckama Vlieg |
| 112 |
[GO] |
2023―Nov―11 |
OC 55.3 Inflammasome Activation in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) After Immunization with Adenovirus-Based SARS-CoV-2 Vaccines |
R. Martins-Gonçalves, D.P. Mendes-De-Almeida, C.Q. Sacramento, S. Vicente Rozini, J. Bokel, G. Vitiello Teixeira, V. Bertollo Gomes Porto, S. Wagner Cardoso, B. Hoagland, P. Mouta Nunes De Oliveira, L. Amorim Filho, B. Grinsztejn, E.D. Hottz, M. De Sousa Maia, P.T. Bozza |
| 113 |
[GO] |
2023―Nov―11 |
PB0352 Non-Pathogenic Anti-PF4 Antibodies after SARS-CoV-2 Vaccines: Long Term Follow-Up |
G. Uzun, K. Althaus, T. Bakchoul |
| 114 |
[GO] |
2023―Nov―11 |
PB0800 Infection with Ancestral SARS-CoV-2 versus Variants of Concern Delta and Omicron Differentially Alter the Megakaryocyte Transcriptome |
M. Sowa, T. Michael, F. Schlamp, M. Samanovic, M. Mulligan, J. Berger, T. Barrett |
| 115 |
[GO] |
2023―Nov―11 |
PB0086 Prospective Assessment of Thrombomodulin Resistance in Oncological Patients and Healthy Subjects Following Vaccination Against Sars-Cov-2 with the mRNAVaccine. The Roadmap-COVID-19-Vaccin Study |
P. Van Dreden, J. Gligorov, E. Terpos, M. Jamelot, M. Grussé, I. Elalamy, J. Fareed, A. Rousseau, M. Dimopoulos, G. Gerotziafas |
| 116 |
[GO] |
2023―Nov―11 |
PB0362 Atypical Hemolytic Uremic Syndrome after SARS-CoV2 Infection with C3 p.I1157 T Mutation |
T. Matsumoto, H. Wada, M. Ikejiri, K. Ino, K. Suzuki, Y. Sugimoto, I. Tawara |
| 117 |
[GO] |
2023―Nov―11 |
OC 05.1 Impact of Low Molecular Weight Heparin (LMWH) on SARS-CoV2 Infection: HEPARIN-SARS-CoV2 Clinical Trial |
R. Otero-Candelera, D. González-Vergara, I. Caparrós-Miranda, E. Mendoza-Zambrano, A. García-Ortega, C. Rodriguez-Matute, J. Moises, L. Martín-Barrera, J. Rodríguez-Martorell |
| 118 |
[GO] |
2023―Nov―11 |
PB0512 Impact of the Pandemic on Anticoagulant Therapy - Preliminary Study |
F. Pires, A. Freixo, C. Câmara, I. Amado, R. Capelo, Á. Beleza |
| 119 |
[GO] |
2023―Nov―11 |
PB1159 Critical Values in Hemostasis Laboratory. Analysis in a 3 Years Period Including Pandemics |
M. Martinuzzo, M. López, C. Berger, L. Barrera |
| 120 |
[GO] |
2023―Nov―11 |
PB0758 Comparative study of Immunothrombotic Biomarkers in Patients with Rheumatologic Diseases and Long COVID |
Y. Ambriz-Murilo, A. Méndez, N. García-Larragoiti, S. López-Castañeda, P. Guzmán-cancino, M. Trujillo, Y. Jiménez-Vega, M. Viveros-Sandoval |
| 121 |
[GO] |
2023―Nov―11 |
PB0090 D-Dimer as an Indirect Marker of Microthrombi in Patients with Long COVID |
L. Del Carpio-Orantes, A. Rosas-Lozano, A. Aguilar-Silva, S. García-Méndez, J. Sánchez-Díaz, S. Hernández-Hernández, R. Salazar-Lizárraga, R. Domínguez-Cámara |
| 122 |
[GO] |
2023―Nov―11 |
PB0068 Pulmonary Sequelae in Long COVID are not Associated with the Carriage of Prothrombotic Genetic Variants |
G. de Larrañaga, P. Rossi, F. Trullas, V. Brichetti, S. Perés, F. Aranda, P. Montesinos, T. Rubilar, A. Crespi, A. Martinez Fraga, M. Sívori, F. Saldarini |
| 123 |
[GO] |
2023―Nov―11 |
PB0061 von Willebrand Factor as a Biomarker of Endothelial Activation/Injury in Long COVID Patients Like What Reported in HIV Patients under Treatment |
G. de Larrañaga, S. Perés, F. Aranda, V. Brichetti, J. Tejada, J. Vázquez, M. Jajati, J. Chamorro, A. Bocassi, T. Rubilar, A. Crespi, M. Sívori, F. Saldarini |
| 124 |
[GO] |
2023―Nov―03 |
COVID-19. Comparison of D-dimer levels measured with three commercial platforms |
Erica Scalambrino, Marigrazia Clerici, Sara Scardo, Marco Capecchi, Claudia Della Noce, Sophie Testa, Flora Peyvandi, Armando Tripodi |
| 125 |
[GO] |
2023―Nov―02 |
Therapeutic-dose heparin in preventing COVID-19-associated acute kidney injury: What about bleeding risk? |
Chia Siang Kow, Kaeshaelya Thiruchelvam |
| 126 |
[GO] |
2023―Nov―01 |
Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: A case series |
Daniela P. Mendes-de-Almeida, Patrícia Mouta Nunes de Oliveira, Victor Bertollo Gomes Porto, Renata Saraiva Pedro, Paulo Roberto Gomes Takey, Letícia Kegele Lignani, Gabriellen Vitiello Teixeira, Tainá dos Santos Pereira, Debora Lima Abreu, Janaína Reis Xavier, Thalita da Matta de Castro, Luiz Melo de Amorim Filho, Maria de Lourdes de Sousa Maia |
| 127 |
[GO] |
2023―Oct―11 |
Venous Thromboembolism in an Asian COVID-19 Cohort Across Three Infection Waves - A Retrospective Observational Study |
Shir Ying Lee, Winnie Z.Y. Teo, Cheryl XQ. Lim, Chun Tsu Lee, Wei-Ying Jen, Sanjay de Mel, Eng Soo Yap, Yen-Lin Chee |
| 128 |
[GO] |
2023―Sep―29 |
Long-term risk of venous thromboembolism after COVID-19 mainly related to ICU-stay based on findings of a self-controlled case series study. |
Ioannis Katsoularis |
| 129 |
[GO] |
2023―Sep―28 |
Platelets of COVID-19 patients display mitochondrial dysfunction, oxidative stress and energy metabolism failure compatible with cell death. |
Valentine Léopold, Osoul Chouchane, Joe M. Butler, Alex R. Schuurman, Erik H.A. Michels, Justin de Brabander, Bauke V. Schomakers, Michel van Weeghel, Daisy I. Picavet-Havik, Anita E. Grootemaat, Renée A. Douma, Tom D.Y. Reijnders, Augustijn M. Klarenbeek, Brent Appelman, Joost Wiersinga, Nicole N. van der Wel, Jeroen den Dunnen, Riekelt H. Houtkooper, Cornelis van ’t Veer, Tom van der Poll |
| 130 |
[GO] |
2023―Sep―20 |
COVID-19-associated Venous Thromboembolism: Risk of Recurrence and Major Bleeding |
Pablo DEMELO-RODRIGUEZ, Rubén ALONSO-BEATO, Luis JARA-PALOMARES, Francisco GALEANO-VALLE, Alessandra BURA-RIVIERE, Adriana VISONÀ, Iria FRANCISCO, Gemma VIDAL, Antonio LÓPEZ-RUIZ, Manuel MONREAL |
| 131 |
[GO] |
2023―Sep―16 |
Effects of Inflammation on Thrombosis and Outcomes in COVID-19: Secondary Analysis of the ATTACC/ACTIV-4a Trial |
Amanda T. Walborn, Anna Heath, Matthew D. Neal, Ryan Zarychanski, Lucy Z. Kornblith, Prof Beverley J. Hunt, Lana A. Castellucci, Judith S. Hochman, Patrick R. Lawler, Jonathan Paul |
| 132 |
[GO] |
2023―Aug―30 |
Citrullination of α2-antiplasmin is unlikely to contribute to enhanced plasmin generation in COVID-19 pathophysiology |
Kadri Kangro, Robert A. Campbell, Ronak Tilvawala, Matthew J. Flick, Alisa S. Wolberg |
| 133 |
[GO] |
2023―Aug―30 |
HTRS2023.O8B.2 Proteome and phosphoproteome analyses of SARS-CoV-2 infected humanized ACE2 mice platelets reveal early hyperactive and late antiviral phenotypes |
Saravanan Subramaniam, Ryan Matthew Hekman, Archana Jayaraman, Aoife Kateri O’Connell, Paige Montanaro, Devin Kenney, Maria Ericsson, Sarah Walachowski, Benjamin Blum, Katya Ravid, Nicholas A. Crossland, Florian Douam, Andrew Emili, Markus Bosmann |
| 134 |
[GO] |
2023―Aug―09 |
Plasma tPA is associated with lipoprotein(a) and clinical outcomes in hospitalized COVID-19 Patients |
Ziyu Zhang, Wen Dai, Wen Zhu, Maya Rodriguez, Hayley Lund, Yuhe Xia, Yiliang Chen, Mary Rau, Ellen Anje Schneider, Mary Beth Graham, Shawn Jobe, Demin Wang, Weiguo Cui, Renren Wen, Sidney W. Whiteheart, Jeremy P. Wood, Roy Silverstein, Jeffery S. Berger, Lisa Baumann Kreuziger, Tessa J. Barrett, Ze Zheng |
| 135 |
[GO] |
2023―Aug―09 |
Effect of Therapeutic-Dose Heparin on Severe Acute Kidney Injury and Death in Non-Critically Ill Patients Hospitalized for COVID-19: A Pre-Specified Secondary Analysis of the ACTIV4a and ATTACC randomized trial |
Nathaniel R. Smilowitz, Erinn M. Hade, Lucy Z. Kornblith, Lana A. Castellucci, Mary Cushman, Michael Farkouh, Michelle N. Gong, Anna Heath, Beverly J. Hunt, Keri S. Kim, Andrei Kindzelski, Patrick Lawler, David E. Leaf, Ewan Goligher, Eric S. Leifer, Bryan J. McVerry, Harmony R. Reynolds, Ryan Zarychanski, Judith S. Hochman, Matthew D. Neal, Jeffrey S. Berger |
| 136 |
[GO] |
2023―Jul―13 |
Exploring heterogeneity in reported venous thromboembolism risk in COVID-19 and comparison to other viral pneumonias: a systematic review and meta-regression |
B.S. Bhoelan, C. Codreanu, Y.I.G.V. Tichelaar, J.F. Borjas Howard, K. Meijer |
| 137 |
[GO] |
2023―Jul―01 |
Thrombotic and hemorrhagic complications of COVID-19 for adults hospitalized in high-income countries compared to low- and middle-income countries in an international registry. |
Matthew J. Griffee, Patricia T. Bozza, Luis Felipe Reyes, Devin P. Eddington, Dorothea Rosenberger, Laura Merson, Barbara Wanjiru Citarella, Jonathon P. Fanning, Peta M.A. Alexander, John Fraser, Heidi Dalton, Sung-Min Cho |
| 138 |
[GO] |
2023―Jun―21 |
Pulmonary embolism and deep venous thrombosis after COVID-19: long-term risk in a population-based cohort study |
Helen Sjoland, Martin Lindgren, Triantafyllia Toska, Per-Olof Hansson, Katarina Glise Sandblad, Christian Alex, Lena Bjorck, Ottmar Cronie, Jonas Bjork, Christina E. Lundberg, Martin Adiels, Annika Rosengren |
| 139 |
[GO] |
2023―Jun―21 |
Podoplanin and CLEC-2 levels in patients with COVID-19 |
Ivanio Teixeira Borba-Junior, Franciele Lima, Davi Sidarta Vitoria Rodrigues Oliveira, Carla Roberta Peachazepi Moraes, Joyce M. Annichino-Bizzacchi, Bruna Bombassaro, André C. Palma, Fabio Trindade Maranhao Costa, Maria Luiza Moretti, Eli Mansour, Licio Augusto Velloso, Fernanda Andrade Orsi, Erich Vinicius De Paula |
| 140 |
[GO] |
2023―May―18 |
Von Willebrand factor and the thrombophilia of severe COVID-19: in situ evidence from autopsies |
Jana van den Berg, Jasmin D. Haslbauer, Anna K. Stalder, Anna Romanens, Kirsten D. Mertz, Jan-Dirk Studt, Martin Siegemund, Andreas Buser, Andreas Holbro, Alexandar Tzankov |
| 141 |
[GO] |
2023―Apr―26 |
VENOUS THROMBOEMBOLISM SECONDARY TO HOSPITALIZATION FOR COVID-19 DISEASE: PATIENT MANAGEMENT AND LONG-TERM OUTCOMES |
Walter Ageno, Emilia Antonucci, Daniela Poli, Eugenio Bucherini, Antonio Chistolini, Vittorio Fregoni, Teresa Lerede, Roberta Pancani, Simona Pedrini, Filippo Pieralli, Pasquale Pignatelli, Attilia Maria Pizzini, Gian Marco Podda, Nicola Potere, Luca Sarti, Sophie Testa, Adriana Visonà, Gualtiero Palareti |
| 142 |
[GO] |
2023―Mar―15 |
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms |
Oscar Borsani, Virginia V. Ferretti, Ilaria C. Casetti, Daniele Vanni, Chiara Trotti, Daniela Pietra, Annalisa De Silvestri, Luca Arcaini, Elisa Rumi |
| 143 |
[GO] |
2023―Mar―08 |
Thrombosis and bleeding in COVID-19 patients requiring extracorporeal membrane oxygenation: A systematic review and meta-analysis |
Yu Jin, Yang Zhang, Jinping Liu, Zhou Zhou |
| 144 |
[GO] |
2023―Feb―15 |
COVID-19 vaccination and immune thrombocytopenia: Cause for vigilance, but not panic |
Hanny Al-Samkari |
| 145 |
[GO] |
2023―Feb―14 |
Endothelial cell activation, Weibel-Palade body secretion and enhanced angiogenesis in severe COVID-19 |
Ellie Karampini, Helen Fogarty, Stephanie Elliott, Hannah Morrin, Colm Bergin, Jamie M. O’Sullivan, Mary Byrne, Ignacio Martin-Loeches, Patrick W. Mallon, Gerard F. Curley, Siobhan Glavey, Ross I. Baker, M. Lavin, Roger J.S. Preston, Cliona Ni Cheallaigh, Soracha E. Ward, James S. O’Donnell |
| 146 |
[GO] |
2023―Feb―08 |
Venous or Arterial Thrombosis in COVID-19 Cases in the North Carolina COVID-19 Community Research Partnership (NC-CCRP) |
Michael E. DeWitt, David M. Herrington, John W. Sanders |
| 147 |
[GO] |
2023―Feb―06 |
Convalescent Plasma Therapy for COVID-19 in Ambulatory vs Hospitalized Patients: Efficacy and Risk of Thromboembolism |
Pei Ye Li, Philip Yu, Allen Li, Faran Khalid, Marissa Liselle Laureano, Mark Andrew Crowther |
| 148 |
[GO] |
2023―Jan―30 |
SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people |
Lamya Garabet, Anna Eriksson, Eirik Tjønnfjord, Xue-Yan Cui, Magnus Kringstad Olsen, Hege Karine Jacobsen, Camilla Tøvik Jørgensen, Åse-Berit Mathisen, Marie-Christine Mowinckel, Maria Therese Ahlen, Ingvild Hausberg Sørvoll, Kjersti Daae Horvei, Siw Leiknes Ernstsen, Ingvild Jenssen Lægreid, Benedicte Stavik, René Holst, Per Morten Sandset, Waleed Ghanima |
| 149 |
[GO] |
2023―Jan―28 |
Early SARS-CoV-2 infection: Platelet-neutrophil complexes and platelet function |
Marina Rieder, Niklas Baldus, Daniela Stallmann, Maren Jeserich, Isabella Goller, Luisa Wirth, Luisa Pollmeier, Maike Hofmann, Christoph Bode, Hans-Joerg Busch, Bonaventura Schmid, Nadine Gauchel, Rüdiger E. Scharf, Daniel Duerschmied, Achim Lother, Krystin Krauel |
| 150 |
[GO] |
2023―Jan―14 |
No changes in haemostasis after COVID-19-heterologous vaccination schedule: a sub analysis of the phase 2 CombiVacS study |
Nora V. Butta, Elena G. Arias-Salgado, Elena Monzón Manzano, Paula Acuña, María Teresa Álvarez Román, Antonio Buño-Soto, Juan Carlos Ramos Ramos, Cristóbal Belda-Iniesta, Jesús Frías, Antonio J. Carcas, Lucía Martínez de Soto, Rosa de Miguel Buckley, David Lora, María Teresa García-Morales, Alberto M. Borobia, José Ramón Arribas, Víctor Jiménez Yuste |
| 151 |
[GO] |
2023―Jan―14 |
Sex Differences in D-Dimer and Critical Illness in COVID-19 Patients: A Systematic Review and Meta-analysis |
Olivia Saville, Malak Elbatarny, Yousra Tera, Yan Deng, Maha Othman |
| 152 |
[GO] |
2023―Jan―11 |
Effects of convalescent plasma infusion on the ADAMTS13-von Willebrand factor axis and endothelial integrity in patients with severe and critical COVID-19 |
Quan Zhang, Zhan Ye, Paul McGowan, Christopher Jurief, Andrew Ly, Antonia Bignotti, Noritaka Yada, X. Long Zheng |
| 153 |
[GO] |
2023―Jan―10 |
Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patients |
Philip Young-Ill Choi, Danny Hsu, Huyen Anh Tran, Chee Wee Tan, Anoop Enjeti, Vivien Mun Yee Chen, Eileen Merriman, Agnes S.M. Yong, Jock Simpson, Elizabeth Gardiner, Nicolas Cherbuin, Jennifer Curnow, Dominic Pepperell, Robert Bird |
| 154 |
[GO] |
2023―Jan―07 |
Outcomes associated with antiphospholipid antibodies in COVID-19: a prospective cohort study |
Arielle Mendel, Marvin J. Fritzler, Yvan St-Pierre, Joyce Rauch, Sasha Bernatsky, Évelyne Vinet |
| 155 |
[GO] |
2022―Nov―16 |
Pulmonary embolism-related mortality during the
COVID
-19 pandemic: Data from the United States |
Karlyn A. Martin, Katharine Harrington, Xiaoning Huang, Sadiya S. Khan |
| 156 |
[GO] |
2022―Nov―16 |
Cerebral vein thrombosis after ChAdOx1 nCov-19 vaccination: Long-term outcome of four patients |
Deepa J. Arachchillage, Christina Crossette-Thambiah, Namir Asmar, Saipriya Ramji, Mike Laffan |
| 157 |
[GO] |
2022―Oct―31 |
Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study |
Matthias M. Engelen, Quentin Van Thillo, Albrecht Betrains, Iwein Gyselinck, Caroline P. Martens, Valérie Spalart, Anna Ockerman, Caroline Devooght, Joost Wauters, Jan Gunst, Carine Wouters, Christophe Vandenbriele, Steffen Rex, Laurens Liesenborghs, Alexander Wilmer, Philippe Meersseman, Greet Van den Berghe, Dieter Dauwe, Ann Belmans, Michiel Thomeer, Tom Fivez, Dieter Mesotten, David Ruttens, Luc Heytens, Ilse Dapper, Sebastiaan Tuyls, Brecht De Tavernier, Peter Verhamme, Thomas Vanassche, Eric Van Wijngaerden, Wim Janssens, Geert Meyfroidt, Robin Vos, Timothy Devos, Paul De Munter, Johan Neyts, Lieven Dupont, Isabel Spriet, Geert Verbeke, Kathleen Claes, Wim Robberecht, Chris Van Geet, Barbara Debaveye, Helga Ceunen, Veerle Servaes, Katrien Cludts, Kristine Vanheule, Cato Jacobs, Daimy Roebroek, Paulien Dreesen, Nele Smet, Jan Dolhain, Mieke Hoppenbrouwers, Kathleen Wens, Kristel Daems, Monique D’hondt |
| 158 |
[GO] |
2022―Jul―21 |
Biomarker derived risk scores predict venous thromboembolism and major bleeding among patients with COVID-19 |
Scott C. Woller, Scott M. Stevens, Joseph R. Bledsoe, Masarret Fazili, James F. Lloyd, Greg L. Snow, Benjamin D. Horne |
| 159 |
[GO] |
2022―Jun―17 |
No association of low-dose aspirin with severe COVID-19 in France: A cohort of 31.1 million people without cardiovascular disease |
Jérémie Botton, Laura Semenzato, Julie Dupouy, Rosemary Dray-Spira, Alain Weill, Olivier Saint-Lary, Mahmoud Zureik |
| 160 |
[GO] |
2022―May―30 |
To escalate thromboprophylacic heparin intensity in COVID-19 or not? That is still the question |
Behnood Bikdeli |
| 161 |
[GO] |
2022―May―26 |
D-dimer testing in clinical practice in the era of COVID-19 |
Claire Auditeau, Lina Khider, Benjamin Planquette, Olivier Sanchez, David M. Smadja, Nicolas Gendron |
| 162 |
[GO] |
2022―May―18 |
Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial |
Marc Blondon, Sara Cereghetti, Jérôme Pugin, Christophe Marti, Pauline Darbellay Farhoumand, Jean-Luc Reny, Alexandra Calmy, Christophe Combescure, Lucia Mazzolai, Olivier Pantet, Zied Ltaief, Marie Méan, Sara Manzocchi Besson, Séverin Jeanneret, Hans Stricker, Helia Robert-Ebadi, Pierre Fontana, Marc Righini, Alessandro Casini |
| 163 |
[GO] |
2022―May―02 |
Platelet-leukocyte interactions in COVID-19: Contributions to hypercoagulability, inflammation, and disease severity |
Eugenio D. Hottz, Patrícia T. Bozza |
| 164 |
[GO] |
2022―Apr―20 |
Risk of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination prior to the recognition of vaccine-induced thrombocytopenia and thrombosis: A self-controlled case series study in England |
Hannah Higgins, Nick Andrews, Julia Stowe, Gayatri Amirthalingam, Mary Ramsay, Gurpreet Bahra, Anthony Hackett, Karen A. Breen, Michael Desborough, Dalia Khan, Heather Leary, Connor Sweeney, Elizabeth Hutchinson, Susan E. Shapiro, Charlotte Lees, Jay Dhanapal, Peter K. MacCallum, Shoshana Burke, Vickie McDonald, Ngai Mun Aiman Entwistle, Stephen Booth, Christina J. Atchison, Beverley J. Hunt |
| 165 |
[GO] |
2022―Apr―15 |
Coagulation factor inhibitors in COVID-19: From SARS-CoV-2 vaccination to infection |
Jeremy W. Jacobs, Brian D. Adkins, Shannon C. Walker, Garrett S. Booth, Allison P. Wheeler |
| 166 |
[GO] |
2022―Apr―05 |
Thromboprophylaxis in COVID-19: Weight and severity adjusted intensified dosing |
Matthias M. Engelen, Christophe Vandenbriele, Valérie Spalart, Caroline P. Martens, Bert Vandenberk, Pieter Sinonquel, Natalie Lorent, Paul De Munter, Rik Willems, Joost Wauters, Alexander Wilmer, Dieter Dauwe, Jan Gunst, Ipek Guler, Stefan Janssens, Kimberly Martinod, Griet Pieters, Kathelijne Peerlinck, Peter Verhamme, Thomas Vanassche |
| 167 |
[GO] |
2022―Mar―21 |
MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID-19 severe respiratory failure (MUST COVID): A retrospective cohort study |
Christopher D. Barrett, Hunter B. Moore, Ernest E. Moore, Dudley Benjamin Christie, Sarah Orfanos, Lorenzo Anez-Bustillos, Rashi Jhunjhunwala, Sabiha Hussain, Shahzad Shaefi, Janice Wang, Negin Hajizadeh, Elias N. Baedorf-Kassis, Ammar Al-Shammaa, Krystal Capers, Valerie Banner-Goodspeed, Franklin L. Wright, Todd Bull, Peter K. Moore, Hannah Nemec, John Thomas Buchanan, Cory Nonnemacher, Natalie Rajcooar, Ramona Ramdeo, Mena Yacoub, Ana Guevara, Aileen Espinal, Laith Hattar, Andrew Moraco, Robert McIntyre, Daniel S. Talmor, Angela Sauaia, Michael B. Yaffe |
| 168 |
[GO] |
2022―Feb―16 |
COVID-19 and venous thromboembolism: A narrative review |
Dana E. Angelini, Scott Kaatz, Rachel P. Rosovsky, Rebecca L. Zon, Shreejith Pillai, William E. Robertson, Pavania Elavalakanar, Rushad Patell, Alok Khorana |
| 169 |
[GO] |
2022―Feb―08 |
Clinical relapse of immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination |
William Deucher, Senthil Sukumar, Spero R. Cataland |
| 170 |
[GO] |
2022―Jan―25 |
The ongoing enigma of SARS-CoV-2 and platelet interaction |
Younes Zaid, Fadila Guessous |
| 171 |
[GO] |
2022―Jan―15 |
Thromboelastography determined dynamics of blood coagulation and its correlation with complications and outcomes in patients with coronavirus disease 2019 |
Tushar Sehgal, Mukul Aggarwal, Upendra Baitha, Gaurav Gupta, Bindu Prakash, Anu Gupta, Ganesh Kumar, Ashutosh Biswas, Maroof Khan |
| 172 |
[GO] |
2022―Jan―15 |
Vaccine-induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV-19 is rare in Asia |
Kochawan Boonyawat, Pantep Angchaisuksiri |
| 173 |
[GO] |
2021―Dec―17 |
Randomized trials of therapeutic heparin for COVID-19: A meta-analysis |
Michelle Sholzberg, Bruno R. Costa, Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, Fionnuala Ní Áinle, Mozah Obaid Almarshoodi, Paula D. James, David Lillicrap, Marc Carrier, Andrew Beckett, Michael Fralick, Saskia Middeldorp, Agnes Y. Y. Lee, Kevin E. Thorpe, Elnara Márcia Negri, Mary Cushman, Peter Jüni |
| 174 |
[GO] |
2021―Nov―21 |
Safety of the second dose of the ChAdOx1 nCoV-19 vaccine in people with persistent anti-platelet factor 4 antibodies |
Noppacharn Uaprasert, Sasinipa Trithiphen, Autcharaporn Sukperm, Benjaporn Akkawat, Phandee Watanaboonyongcharoen, Rattaporn Vichitratchaneekorn, Thanisa Tongbai, Watsamon Jantarabenjakul, Leilani Paitoonpong, Ponlapat Rojnuckarin |
| 175 |
[GO] |
2021―Nov―03 |
The path of uncovering a prothrombotic thrombocytopenic syndrome after viral vector-based COVID-19 vaccination: Where there is much light, the shadow is deep |
Johannes Thaler, Cihan Ay, Paul Knoebl |
| 176 |
[GO] |
2021―Oct―16 |
Stability of vitamin K antagonist anticoagulation after COVID-19 diagnosis |
Eleonora Camilleri, Nienke van Rein, Felix J. M. van der Meer, Melchior C. Nierman, Willem M. Lijfering, Suzanne C. Cannegieter |
| 177 |
[GO] |
2021―Oct―12 |
Prevalence of anti-platelet factor 4/polyanionic antibodies after COVID-19 vaccination with ChAdOx1 nCoV-19 and CoronaVac in Thais |
Phichchapha Noikongdee, Pornnapa Police, Tichayapa Phojanasenee, Pichika Chantrathammachart, Pimjai Niparuck, Teeraya Puavilai, Angsana Phuphuakrat, Pantep Angchaisuksiri, Kochawan Boonyawat |
| 178 |
[GO] |
2021―Sep―25 |
Hemostasis and fibrinolysis in COVID-19 survivors 6 months after intensive care unit discharge |
Anne-Marije Hulshof, Dionne C. W. Braeken, Chahinda Ghossein-Doha, Susanne van Santen, Jan-Willem E. M. Sels, Gerhardus J. A. J. M. Kuiper, Iwan C. C. van der Horst, Hugo ten Cate, Bas C. T. Bussel, Renske H. Olie, Yvonne M. C. Henskens |
| 179 |
[GO] |
2021―Sep―18 |
Prevalence of thrombocytopenia, anti-platelet factor 4 antibodies and D-dimer elevation in Thai people After ChAdOx1 nCoV-19 vaccination |
Noppacharn Uaprasert, Phandee Watanaboonyongcharoen, Rattaporn Vichitratchaneekorn, Sasinipa Trithiphen, Benjaporn Akkawat, Autcharaporn Sukperm, Thanisa Tongbai, Watsamon Jantarabenjakul, Leilani Paitoonpong, Ponlapat Rojnuckarin |
| 180 |
[GO] |
2021―Sep―13 |
Severe COVID-19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis |
Golzar Mobayen, Amrita Dhutia, Candice Clarke, Maria Prendecki, Stephen McAdoo, Renos Keniyopoullos, Talat Malik, Michael Laffan, Michelle Willicombe, Thomas McKinnon |
| 181 |
[GO] |
2021―Aug―25 |
Vaccine-induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine-A case report |
Bader Al Rawahi, Hashem BaTaher, Zoheb Jaffer, Aya Al-Balushi, Asma Al-Mazrouqi, Noof Al-Balushi |
| 182 |
[GO] |
2021―Jun―28 |
Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors |
Alex C. Spyropoulos, Dimitrios Giannis, Mark Goldin |
| 183 |
[GO] |
2021―May―19 |
Comparison of the coagulopathies associated with COVID-19 and sepsis |
Robert A. Campbell, Yohei Hisada, Frederik Denorme, Steven P. Grover, Emma G. Bouck, Elizabeth A. Middleton, Alisa S. Wolberg, Matthew T. Rondina, Nigel Mackman |
| 184 |
[GO] |
2021―May―08 |
Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study |
Lachelle D. Weeks, Katelyn W. Sylvester, Jean M. Connors, Nathan T. Connell |
| 185 |
[GO] |
2021―Mar―08 |
Caging the dragon: Research approach to COVID-19-related thrombosis |
Marieke J. H. A. Kruip, Suzanne C. Cannegieter, Hugo ten Cate, Eric C. M. Gorp, Nicole P. Juffermans, Frederikus A. Klok, Coen Maas, Anton Vonk-Noordegraaf |
| 186 |
[GO] |
2021―Feb―24 |
Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19 |
Alex C. Spyropoulos, Stuart L. Cohen, Eugenia Gianos, Nina Kohn, Dimitrios Giannis, Saurav Chatterjee, Mark Goldin, Marty Lesser, Kevin Coppa, Jamie S. Hirsch, Thomas McGinn, Matthew A. Barish |
| 187 |
[GO] |
2021―Feb―18 |
Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients |
MAM Stals, MJJH Grootenboers, C van Guldener, FHJ Kaptein, SJE Braken, Q Chen, G Chu, EM van Driel, A Iglesias del Sol, E de Jonge, KM Kant, F Pals, MMA Toorop, SC Cannegieter, FA Klok, MV Huisman |
| 188 |
[GO] |
2021―Jan―15 |
Vascular thromboembolic events following COVID-19 hospital discharge: incidence and risk factors |
Harish Eswaran, Jamie A. Jarmul, Amy W. Shaheen, David Meaux, Tristan Long, Derek Saccoccio, Stephan Moll |
| 189 |
[GO] |
2021―Jan―05 |
COVID-19-related prothrombotic changes increase with lung injury and remain unaffected by anticoagulation therapy |
Alice Assinger |
| 190 |
[GO] |
2020―Dec―07 |
Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality |
Fien A. Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Annika Lundström, Ann-Sofie Rudberg, Maria Magnusson, Nigel Mackman, Charlotte Thalin, Ton Lisman |
| 191 |
[GO] |
2020―Nov―10 |
eThrombosis: A new risk factor for venous thromboembolism in the pandemic era |
Daisuke Sueta, Koichi Kaikita, Kenichi Matsushita, Kenichi Tsujita |
| 192 |
[GO] |
2020―Oct―21 |
Harmonizing Hypercoagulable Heterogeneity: Baseline VTE Risk in COVID-19 |
George Goshua, Alfred Ian Lee |
| 193 |
[GO] |
2020―Sep―28 |
COVID-19 pandemic perspectives: A scientific silver lining? |
Dre'Von A. Dobson, Alisa S. Wolberg |
| 194 |
[GO] |
2020―Sep―25 |
Thrombo-inflammation response to Tocilizumab in COVID-19 |
Mansour Gergi, Mary Cushman, Benjamin Littenberg, Ralph C. Budd |
| 195 |
[GO] |
2020―Sep―25 |
Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis |
Stephan Nopp, Florian Moik, Bernd Jilma, Ingrid Pabinger, Cihan Ay |
| 196 |
[GO] |
2020―Sep―19 |
Left ventricular thrombus and pulmonary embolism: A case series of thrombosis in COVID-19 in Thai patients |
Nithita Nanthatanti, Sithakom Phusanti, Pichika Chantrathammachart, Kanin Thammavaranucupt, Pantep Angchaisuksiri, Somnuek Sungkanuparph |
| 197 |
[GO] |
2020―Jul―14 |
The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19 |
Jori E. May, Rance C. Siniard, Marisa Marques |
| 198 |
[GO] |
2020―Jul―11 |
Thrombosis and coagulopathy in COVID-19: An illustrated review |
Marcel Levi, Beverley J. Hunt |
| 199 |
[GO] |
2020―Jul―09 |
Response to The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19 |
Richard R. Riker, Teresa L. May, Gilles L. Fraser, David J. Gagnon, Mahesh Bandara, Wes Zemrak, David B. Seder |
| 200 |
[GO] |
2020―Jul―09 |
Anticoagulation Practice Patterns in COVID-19: A Global Survey |
Rachel P. Rosovsky, Kristen M Sanfilippo, Tzu Fei Wang, Sandeep K. Rajan, Surbhi Shah, Karlyn A. Martin, Fionnuala Ní Áinle, Menno Huisman, Beverley J Hunt, Susan R. Kahn, Barry Kevane, Agnes YY. Lee, Claire McLintock, Lisa Baumann Kreuziger |
| 201 |
[GO] |
2020―Jun―25 |
Staying updated on COVID-19: social media to amplify science in thrombosis and haemostasis |
Mike Makris |
| 202 |
[GO] |
2020―Jun―14 |
The underrecognized prothrombotic vascular disease of COVID-19 |
Kevin P. Cohoon, Guillaume Mahé, Alex C. Spyropoulos |
| 203 |
[GO] |
2020―Jun―08 |
Gender gap in women authors is not worse during COVID-19 pandemic: Results from Research and Practice in Thrombosis and Haemostasis |
Mary Cushman |
| 204 |
[GO] |
2020―May―29 |
Anticoagulation, Immortality, and Observations of COVID-19 |
Jason H. Maley, Camille R. Petri, Laura N. Brenner, Raghu R. Chivukula, Tiara F. Calhoun, Vladimir Vinarsky, C. Corey Hardin |
| 205 |
[GO] |
2020―May―29 |
Potential Role of Platelets in COVID-19: Implications for Thrombosis |
Milka Koupenova |
| 206 |
[GO] |
2020―May―21 |
STudy of Alteplase for Respiratory failure in SARS-Cov2/COVID-19: Study Design of the Phase IIa STARS Trial |
Hunter B. Moore, Christopher D. Barrett, Ernest E. Moore, Rashi Jhunjhnuwala, Robert C. McIntyre, Peter K Moore, Janice Wang, Negin Hajizadeh, Daniel S. Talmor, Angela Sauaia, Michael B. Yaffe |
| 207 |
[GO] |
2020―May―20 |
Heparin-induced Thrombocytopenia with Thrombosis in COVID-19 Adult Respiratory Distress Syndrome |
Richard R. Riker, Teresa L. May, Gilles L. Fraser, David J. Gagnon, Mahesh Bandara, Wes Zemrak, David B. Seder |
| 208 |
[GO] |
2020―May―20 |
Pulmonary embolism during the COVID-19 pandemic: decline in diagnostic procedures and incidence at a University Hospital |
Stephan Nopp, Karin Janata-Schwatczek, Helmut Prosch, Ihor Shulym, Oliver Königsbrügge, Ingrid Pabinger, Cihan Ay |
| 209 |
[GO] |
2020―May―14 |
Venous Thromboembolism in Critically Ill Patients with Covid-19: Results of a Screening Study for Deep Vein Thrombosis |
Alban Longchamp, Justine Longchamp, Sara Manzocchi-Besson, Livia Whiting, Claude Haller, Séverin Jeanneret, Manoelle Godio, Juan Jose Garcia Martinez, Thierry Bonjour, Mary Caillat, Guillaume Maitre, Julian Matthias Thaler, Rémy Pantet, Viviane Donner, Alexis Dumoulin, Stéphane Emonet, Gilbert Greub, Raymond Friolet, Helia Robert-Ebadi, Marc Righini, Bienvenido Sanchez, Julie Delaloye |
| 210 |
[GO] |
2020―May―11 |
A Proposal for Staging COVID-19 Coagulopathy |
Jecko Thachil, Mary Cushman, Alok Srivastava |
| 211 |
[GO] |
2020―May―06 |
Thrombosis and Thromboembolism Related to COVID-19 A clarion call for obtaining solid estimates from large-scale multicenter data |
Stefano Barco, Stavros V Konstantinides |
| 212 |
[GO] |
2020―May―04 |
COVID-19 Hypothesis: Activated Protein C for Therapy of Virus-induced Pathologic Thromboinflammation |
John H. Griffin, Patrick Lyden |
| 213 |
[GO] |
2020―Apr―28 |
Fibrinolytic Therapy for Refractory COVID-19 Acute Respiratory Distress Syndrome: Scientific Rationale and Review |
Christopher D. Barrett, Hunter B. Moore, Ernest E. Moore, Robert C. McIntyre, Peter K Moore, John Burke, Fei Hua, Joshua Apgar, Daniel S. Talmor, Angela Sauaia, Deborah R. Liptzin, Livia A. Veress, Michael B. Yaffe |
| 214 |
[GO] |
2020―Apr―28 |
Emergence of Institutional Antithrombotic Protocols for Coronavirus 2019 |
Kevin P. Cohoon, Guillaume Mahé, Alfonso J. Tafur, Alex C. Spyropoulos |
| 215 |
[GO] |
2020―Apr―21 |
COVID-19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance |
Suzanne C Cannegieter, Frederikus A Klok |
| 216 |
[GO] |
2020―Apr―18 |
The Contact Activation System as a Potential Therapeutic Target in Patients with COVID-19 |
JJ Shatzel, EP DeLoughery, CU Lorentz, EI Tucker, JE Aslan, MT Hinds, D Gailani, JI Weitz, OJT McCarty, A Gruber |
|
